Melanocyte protein Pmel 17 precursor (46-57)

Melanocyte protein PMEL;gp100;pmel 17

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.

CAT No: ta-043

Synonyms/Alias:Melanocyte protein Pmel 17 precursor (46-57)

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
Sequence
RQLYPEWTEAQR
Areas of Interest
Antigen-presenting Cells; Cancer Research

Melanocyte protein Pmel 17 precursor (46-57) is a synthetic peptide fragment derived from the Pmel 17 protein, a key component involved in the biogenesis of melanosomes within melanocytes. As a segment corresponding to amino acids 46 through 57 of the precursor sequence, this peptide represents a region of the Pmel 17 protein that is significant in the context of pigment cell biology and structural studies. The Pmel 17 protein, also known as gp100 or Silver locus protein, plays a critical role in the formation of fibrillar structures that serve as scaffolding for melanin deposition, making its peptide fragments valuable tools for investigating the underlying mechanisms of melanosome maturation and function. Researchers utilize such peptides to explore molecular interactions, post-translational modifications, and antigenic properties relevant to melanocyte physiology and pigment-related disorders.

Epitope mapping: The peptide corresponding to the 46-57 region of the Pmel 17 precursor is frequently used in epitope mapping studies to identify and characterize antigenic determinants within the Pmel 17 protein. By employing this defined sequence, investigators can assess antibody specificity, delineate immune recognition sites, and refine monoclonal antibody development for research applications. Such mapping is crucial for understanding immune responses to melanocyte-associated antigens and supports the design of immunoassays or immunohistochemical protocols targeting pigment cell markers.

Melanosome biogenesis research: As a functional motif within the Pmel 17 protein, the 46-57 peptide fragment serves as a model substrate in studies dissecting the molecular events of melanosome formation and maturation. Scientists utilize this peptide to examine protein-protein interactions, investigate the assembly of amyloid-like fibrils, and elucidate the structural transitions that underpin pigment granule development. These insights contribute to a deeper understanding of organelle biogenesis in pigment cells and facilitate the identification of regulatory factors influencing melanin synthesis.

Peptide-based assay development: The defined sequence of this peptide fragment enables its application in the development and optimization of peptide-based assays, including enzyme-linked immunosorbent assays (ELISAs) and binding studies. By serving as a standardized antigen or binding substrate, the peptide allows for precise quantification of antibody reactivity, assessment of peptide-protein interactions, and validation of assay specificity. Such assays are widely used in basic research and quality control settings where accurate detection of melanocyte-specific proteins is required.

Structural analysis: The Melanocyte protein Pmel 17 precursor (46-57) peptide is employed in structural biology investigations to probe the conformational properties of Pmel 17-derived sequences. Researchers leverage this peptide in biophysical studies, such as circular dichroism spectroscopy or nuclear magnetic resonance (NMR), to elucidate secondary structure tendencies, aggregation behavior, or folding motifs. These analyses provide valuable information about the intrinsic properties of the Pmel 17 protein and its propensity to form functional amyloid fibrils within melanosomes.

Antigen processing studies: The peptide fragment is also utilized in research focused on antigen processing and presentation pathways, particularly in the context of melanocyte-associated proteins. By investigating how this defined sequence is processed and presented by antigen-presenting cells, scientists can uncover mechanisms of immune surveillance, tolerance, or autoimmunity related to pigment cell antigens. Such studies enhance the understanding of melanocyte immunobiology and support the development of research tools for monitoring antigen-specific immune responses.

Source#
Homo sapiens (human)
Epitope
46-57
Restricting HLA
HLA-DRB1
References
Shuming Chen; J Immunol 2013

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Epitope Mapping ServicesPeptide Modification ServicescGMP Peptide ServicePeptide Analysis ServicesCustom Conjugation ServicePeptide Nucleic Acids SynthesisPeptide CDMOPeptide Synthesis Services
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers